Can Losartan (angiotensin II receptor antagonist) cause visual disturbances?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Losartan can potentially cause vision changes, although it is not directly mentioned as a common side effect in the provided evidence. The study 1 discusses medications linked to drug-induced photosensitivity, listing angiotensin receptor blockers, including losartan, as potential causes. However, it does not specifically address vision changes as a side effect.

Key Points to Consider

  • Losartan, an angiotensin II receptor blocker (ARB), may have occasional visual side effects, but the provided evidence does not directly support this claim.
  • The mechanism behind potential visual disturbances could relate to how ARBs affect blood vessels throughout the body, including those in the eye.
  • If vision changes occur while taking losartan, patients should contact their healthcare provider promptly rather than discontinuing the medication on their own.
  • Regular eye examinations are crucial while taking blood pressure medications, especially for patients with other risk factors for eye problems, such as diabetes.

Clinical Implications

Given the potential for vision changes, albeit not directly supported by the provided evidence, it is essential for patients taking losartan to be aware of this possible side effect and report any changes in vision to their healthcare provider. This allows for timely assessment and potential adjustment of the treatment plan to minimize risks to the patient's morbidity, mortality, and quality of life.

From the Research

Losartan and Vision Changes

  • Losartan is an angiotensin II receptor blocker (ARB) that has been studied for its effects on various conditions, including hypertension and eye diseases 2, 3, 4, 5, 6.
  • Research has shown that losartan may have a protective effect on retinal ganglion cells and alter scleral remodeling in experimental glaucoma 3.
  • Topical losartan has been suggested as a potential treatment for corneal scarring fibrosis and other eye diseases and disorders where TGF beta plays a central role in pathophysiology 4.
  • Studies have also investigated the efficacy and duration of action of losartan in patients with essential hypertension, with results showing that losartan may not persist throughout 24 hours when administered once daily in the morning 5.
  • The effects of losartan on cerebral and ocular circulation in healthy subjects have also been studied, with results suggesting that losartan may increase fundus pulsation amplitude and tend to increase resistive index in the ophthalmic artery 6.

Potential Vision-Related Side Effects

  • While losartan may have potential benefits for certain eye conditions, there is limited information available on its potential vision-related side effects.
  • None of the studies provided directly address the question of whether losartan can cause vision changes.
  • However, the study on the effects of losartan on cerebral and ocular circulation in healthy subjects suggests that losartan may have some effects on ocular haemodynamics, although the clinical significance of these effects is unclear 6.

Conclusion Not Provided

As per the instructions, no conclusion will be provided. The information presented is based on the available evidence and is intended to provide a summary of the research on losartan and its potential effects on vision.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.